CytoDyn Gross Margin 2011-2025 | CYDY

Current and historical gross margin for CytoDyn (CYDY) over the last 10 years. The current gross profit margin for CytoDyn as of August 31, 2025 is %.
CytoDyn Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-05-31 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.315B $0.000B
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in humans and is currently in Phase 3 development. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several months of interruption from conventional drug therapy.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $78.129B 29.67
Zoetis (ZTS) US $52.791B 18.89
Takeda Pharmaceutical (TAK) JP $43.625B 8.90
Daiichi Sankyo, - (DSNKY) JP $40.634B 20.24
BeOne Medicines - (ONC) CH $36.101B 191.40
Sandoz Group AG (SDZNY) CH $29.630B 0.00
United Therapeutics (UTHR) US $19.545B 17.20
Merck (MKKGY) DE $16.472B 10.71
Neurocrine Biosciences (NBIX) US $14.958B 35.89
Shionogi (SGIOY) JP $14.547B 13.36
Summit Therapeutics (SMMT) US $14.112B 0.00
IPSEN (IPSEY) FR $12.438B 0.00
Ionis Pharmaceuticals (IONS) US $11.264B 0.00
Madrigal Pharmaceuticals (MDGL) US $11.262B 0.00
Orion OYJ (ORINY) FI $8.719B 24.91
Eisai (ESAIY) $8.283B 0.00
Corcept Therapeutics (CORT) US $7.941B 85.78
Stevanato Group S.p.A (STVN) IT $7.344B 41.10
Grifols, S.A (GRFS) ES $5.913B 0.00
Ono Pharmaceutical (OPHLF) JP $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) GB $4.546B 0.00
NewAmsterdam Pharma (NAMS) NL $4.389B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $3.606B 17.13
Centessa Pharmaceuticals (CNTA) GB $2.990B 0.00
Hypermarcas (HYPMY) BR $2.983B 22.43
Procaps Group, S.A (PROCF) LU $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.650B 8.45
Dyne Therapeutics (DYN) US $2.644B 0.00
Soleno Therapeutics (SLNO) US $2.487B 0.00
Ocular Therapeutix (OCUL) US $2.307B 0.00
Guardian Pharmacy Services (GRDN) US $1.884B 36.28
Collegium Pharmaceutical (COLL) US $1.376B 6.81
Amylyx Pharmaceuticals (AMLX) US $1.338B 0.00
Xeris Biopharma Holdings (XERS) US $1.281B 0.00
Harrow (HROW) US $1.263B 77.59
Nektar Therapeutics (NKTR) US $1.179B 0.00
Oruka Therapeutics (ORKA) US $1.161B 0.00
Enliven Therapeutics (ELVN) US $1.108B 0.00
Relay Therapeutics (RLAY) US $1.069B 0.00
Evotec AG (EVO) DE $1.062B 0.00
Xencor (XNCR) US $0.981B 0.00
Cronos Group (CRON) CA $0.980B 0.00
ARS Pharmaceuticals (SPRY) US $0.878B 0.00
Organogenesis (ORGO) US $0.830B 0.00
ProKidney (PROK) US $0.795B 0.00
Theravance Biopharma (TBPH) US $0.759B 32.08
Savara (SVRA) US $0.691B 0.00
Esperion Therapeutics (ESPR) US $0.689B 0.00
Elite Pharmaceuticals (ELTP) US $0.680B 0.00
Rigel Pharmaceuticals (RIGL) US $0.627B 5.60
Bioventus (BVS) US $0.619B 12.69
KalVista Pharmaceuticals (KALV) US $0.550B 0.00
Zevra Therapeutics (ZVRA) US $0.512B 0.00
4D Molecular Therapeutics (FDMT) US $0.475B 0.00
Siga Technologies (SIGA) US $0.466B 6.38
Lexeo Therapeutics (LXEO) US $0.460B 0.00
Altimmune (ALT) US $0.445B 0.00
Akebia Therapeutics (AKBA) US $0.443B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.411B 9.73
USANA Health Sciences (USNA) US $0.351B 9.79
Nature's Sunshine Products (NATR) US $0.346B 20.60
Lyell Immunopharma (LYEL) US $0.340B 0.00
Galectin Therapeutics (GALT) US $0.335B 0.00
Aldeyra Therapeutics (ALDX) US $0.309B 0.00
Korro Bio (KRRO) US $0.306B 0.00
Pyxis Oncology (PYXS) US $0.297B 0.00
Larimar Therapeutics (LRMR) US $0.294B 0.00
Achieve Life Sciences (ACHV) CA $0.237B 0.00
Journey Medical (DERM) US $0.235B 0.00
Aclaris Therapeutics (ACRS) US $0.231B 0.00
OmniAb (OABI) US $0.214B 0.00
AleAnna (ANNA) US $0.214B 0.00
Heron Therapeutics (HRTX) US $0.204B 0.00
MediWound (MDWD) IL $0.199B 0.00
Profound Medical (PROF) CA $0.181B 0.00
Protara Therapeutics (TARA) US $0.175B 0.00
Innate Pharma SA (IPHYF) FR $0.168B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.165B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.148B 0.00
Cassava Sciences (SAVA) US $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.128B 0.00
Incannex Healthcare (IXHL) AU $0.126B 0.00
Avita Medical (RCEL) US $0.121B 0.00
Inhibikase Therapeutics (IKT) US $0.118B 0.00
Context Therapeutics (CNTX) US $0.110B 0.00
Cardiol Therapeutics (CRDL) CA $0.104B 0.00
Surrozen (SRZN) US $0.101B 0.00
Relmada Therapeutics (RLMD) US $0.100B 0.00
Vivani Medical (VANI) US $0.096B 0.00
Champions Oncology (CSBR) US $0.093B 33.90
Karyopharm Therapeutics (KPTI) US $0.093B 0.00
VAXART, INC (VXRT) US $0.091B 0.00
Gain Therapeutics (GANX) US $0.090B 0.00
Unicycive Therapeutics (UNCY) US $0.083B 0.00
Metagenomi (MGX) US $0.081B 0.00
Lite Strategy (LITS) US $0.081B 0.00
Dominari Holdings (DOMH) US $0.080B 0.00
Plus Therapeutics (PSTV) US $0.077B 0.00
Nutriband (NTRB) US $0.072B 0.00
Prelude Therapeutics (PRLD) US $0.071B 0.00
PMV Pharmaceuticals (PMVP) US $0.069B 0.00
Rafael Holdings (RFL) US $0.067B 0.00
Acrivon Therapeutics (ACRV) US $0.064B 0.00
BioNxt Solutions (BNXTF) CA $0.062B 0.00
PolyPid (PYPD) IL $0.059B 0.00
Talphera (TLPH) US $0.059B 0.00
Fractyl Health (GUTS) US $0.056B 0.00
Wellgistics Health (WGRX) US $0.053B 0.00
NRx Pharmaceuticals (NRXP) US $0.050B 0.00
ElectroCore (ECOR) US $0.050B 0.00
Jupiter Neurosciences (JUNS) US $0.048B 0.00
Century Therapeutics (IPSC) US $0.047B 0.00
FibroGen (FGEN) US $0.044B 0.00
Telomir Pharmaceuticals (TELO) US $0.044B 0.00
Tempest Therapeutics (TPST) US $0.043B 0.00
Klotho Neurosciences (KLTO) US $0.039B 0.00
Inotiv (NOTV) US $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.038B 0.00
Verrica Pharmaceuticals (VRCA) US $0.037B 0.00
Mural Oncology (MURA) IE $0.036B 0.00
Liminatus Pharma (LIMN) US $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.030B 24.75
Iterum Therapeutics (ITRM) IE $0.029B 0.00
Cosmos Health (COSM) US $0.025B 0.00
SCYNEXIS (SCYX) US $0.025B 0.00
Enlivex Therapeutics (ENLV) IL $0.024B 0.00
Scienture Holdings (SCNX) US $0.024B 0.00
Mangoceuticals (MGRX) US $0.022B 0.00
Citius Pharmaceuticals (CTXR) US $0.022B 0.00
Vyome Holdings (HIND) US $0.020B 0.00
Heatwurx (PCSA) US $0.020B 0.00
Vivos Therapeutics (VVOS) US $0.019B 0.00
Mannatech (MTEX) US $0.018B 0.00
Natural Alternatives (NAII) US $0.017B 0.00
CASI Pharmaceuticals (CASI) CN $0.016B 0.00
Lipocine (LPCN) US $0.016B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
BioLineRx (BLRX) IL $0.015B 0.00
Traws Pharma (TRAW) US $0.014B 0.02
Ainos (AIMD) US $0.013B 0.00
Ernexa Therapeutics (ERNA) US $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.013B 0.00
ProPhase Labs (PRPH) US $0.012B 0.00
VYNE Therapeutics (VYNE) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Kiora Pharmaceuticals (KPRX) US $0.009B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
Aptorum Group (APM) GB $0.007B 0.00
Biomerica (BMRA) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
Nuvilex (PMCB) US $0.006B 0.00
Alaunos Therapeutics (TCRT) US $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.005B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.005B 0.00
Quoin Pharmaceuticals (QNRX) US $0.005B 0.00
InMed Pharmaceuticals (INM) CA $0.005B 0.00
Qualigen Therapeutics (QLGN) US $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Jaguar Animal Health (JAGX) US $0.004B 0.00
CDT Equity (CDT) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.003B 0.00
Indaptus Therapeutics (INDP) US $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.003B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
SciSparc (SPRC) IL $0.001B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Aditxt (ADTX) US $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) US $0.000B 0.00
Emisphere Technologies (EMIS) US $0.000B 0.00
Indivior (INDV) US $0.000B 15.76
4D Pharma (LBPS) GB $0.000B 0.00
Minerva Neurosciences (NERV) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00